Literature DB >> 18218633

Reduced dNTP binding affinity of 3TC-resistant M184I HIV-1 reverse transcriptase variants responsible for viral infection failure in macrophage.

Varuni K Jamburuthugoda1, Jose M Santos-Velazquez, Mark Skasko, Darwin J Operario, Vandana Purohit, Pauline Chugh, Erika A Szymanski, Joseph E Wedekind, Robert A Bambara, Baek Kim.   

Abstract

We characterized HIV-1 reverse transcriptase (RT) variants either with or without the (-)-2',3'-deoxy-3'-thiacytidine-resistant M184I mutation isolated from a single HIV-1 infected patient. First, unlike variants with wild-type M184, M184I RT variants displayed significantly reduced DNA polymerase activity at low dNTP concentrations, which is indicative of reduced dNTP binding affinity. Second, the M184I variant displayed a approximately 10- to 13-fold reduction in dNTP binding affinity, compared with the Met-184 variant. However, the k(pol) values of these two RTs were similar. Third, unlike HIV-1 vectors with wild-type RT, the HIV-1 vector harboring M184I RT failed to transduce cell types containing low dNTP concentrations, such as human macrophage, likely due to the reduced DNA polymerization activity of the M184I RT under low cellular dNTP concentration conditions. Finally, we compared the binary complex structures of wild-type and M184I RTs. The Ile mutation at position 184 with a longer and more rigid beta-branched side chain, which was previously known to alter the RT-template interaction, also appears to deform the shape of the dNTP binding pocket. This can restrict ground state dNTP binding and lead to inefficient DNA synthesis particularly at low dNTP concentrations, ultimately contributing to viral replication failure in macrophage and instability in vivo of the M184I mutation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218633      PMCID: PMC2431026          DOI: 10.1074/jbc.M710149200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.

Authors:  H Q Gao; P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  J Mol Biol       Date:  2000-07-07       Impact factor: 5.469

2.  Limiting deoxynucleoside triphosphate concentrations emphasize the processivity defect of lamivudine-resistant variants of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  N K Back; B Berkhout
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

Review 3.  Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates.

Authors:  K A Johnson
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

4.  Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

Authors:  N K Back; M Nijhuis; W Keulen; C A Boucher; B O Oude Essink; A B van Kuilenburg; A H van Gennip; B Berkhout
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

5.  Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase.

Authors:  B B Oude Essink; N K Back; B Berkhout
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

6.  Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1.

Authors:  M Hsu; P Inouye; L Rezende; N Richard; Z Li; V R Prasad; M A Wainberg
Journal:  Nucleic Acids Res       Date:  1997-11-15       Impact factor: 16.971

Review 7.  Physiological concentrations of purines and pyrimidines.

Authors:  T W Traut
Journal:  Mol Cell Biochem       Date:  1994-11-09       Impact factor: 3.396

8.  High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  C A Boucher; N Cammack; P Schipper; R Schuurman; P Rouse; M A Wainberg; J M Cameron
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

9.  Genetic selection in Escherichia coli for active human immunodeficiency virus reverse transcriptase mutants.

Authors:  B Kim
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

10.  Mechanism of inhibition of the human immunodeficiency virus type 1 reverse transcriptase by d4TTP: an equivalent incorporation efficiency relative to the natural substrate dTTP.

Authors:  J A Vaccaro; K M Parnell; S A Terezakis; K S Anderson
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.938

View more
  21 in total

1.  Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.

Authors:  Lu Gao; Mark Nils Hanson; Mini Balakrishnan; Paul L Boyer; Bernard P Roques; Stephen H Hughes; Baek Kim; Robert A Bambara
Journal:  J Biol Chem       Date:  2008-01-24       Impact factor: 5.157

2.  Abundant non-canonical dUTP found in primary human macrophages drives its frequent incorporation by HIV-1 reverse transcriptase.

Authors:  Edward M Kennedy; Waaqo Daddacha; Rebecca Slater; Christina Gavegnano; Emilie Fromentin; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

3.  A role of template cleavage in reduced excision of chain-terminating nucleotides by human immunodeficiency virus type 1 reverse transcriptase containing the M184V mutation.

Authors:  Antonio J Acosta-Hoyos; Suzanne E Matsuura; Peter R Meyer; Walter A Scott
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

4.  Selective modification of adenovirus replication can be achieved through rational mutagenesis of the adenovirus type 5 DNA polymerase.

Authors:  Cristina Capella; Michael-John Beltejar; Caitlin Brown; Vincent Fong; Waaqo Daddacha; Baek Kim; Stephen Dewhurst
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  Subunit-selective mutational analysis and tissue culture evaluations of the interactions of the E138K and M184I mutations in HIV-1 reverse transcriptase.

Authors:  Hong-Tao Xu; Maureen Oliveira; Peter K Quashie; Matthew McCallum; Yingshan Han; Yudong Quan; Bluma G Brenner; Mark A Wainberg
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

6.  Host SAMHD1 protein promotes HIV-1 recombination in macrophages.

Authors:  Laura A Nguyen; Dong-Hyun Kim; Michele B Daly; Kevin C Allan; Baek Kim
Journal:  J Biol Chem       Date:  2013-12-18       Impact factor: 5.157

7.  The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication.

Authors:  Sarah K Van Cor-Hosmer; Waaqo Daddacha; Z Kelly; Amy Tsurumi; Edward M Kennedy; Baek Kim
Journal:  Virology       Date:  2011-12-05       Impact factor: 3.616

8.  Pre-steady state kinetic analysis of HIV-1 reverse transcriptase for non-canonical ribonucleoside triphosphate incorporation and DNA synthesis from ribonucleoside-containing DNA template.

Authors:  Laura A Nguyen; Robert A Domaoal; Edward M Kennedy; Dong-Hyun Kim; Raymond F Schinazi; Baek Kim
Journal:  Antiviral Res       Date:  2014-12-31       Impact factor: 5.970

9.  Restricted 5'-end gap repair of HIV-1 integration due to limited cellular dNTP concentrations in human primary macrophages.

Authors:  Sarah K Van Cor-Hosmer; Dong-Hyun Kim; Michele B Daly; Waaqo Daddacha; Baek Kim
Journal:  J Biol Chem       Date:  2013-10-04       Impact factor: 5.157

10.  Ribonucleoside triphosphates as substrate of human immunodeficiency virus type 1 reverse transcriptase in human macrophages.

Authors:  Edward M Kennedy; Christina Gavegnano; Laura Nguyen; Rebecca Slater; Amanda Lucas; Emilie Fromentin; Raymond F Schinazi; Baek Kim
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.